Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Plasma Cell Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00477971
What this trial is testing

Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 89
Testing effectiveness (Phase 2)Study completedNCT03238599
What this trial is testing

Pedometer Activity Monitoring After ASCT

Who this might be right for
LymphomaMyelomaHigh-dose Chemotherapy+1 more
Insel Gruppe AG, University Hospital Bern 62
Large-scale testing (Phase 3)Study completedNCT03217812
What this trial is testing

VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-Dose Therapy (Asia Pacific Region)

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 220
Large-scale testing (Phase 3)Study completedNCT00507416
What this trial is testing

Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 502
Testing effectiveness (Phase 2)Looking for participantsNCT06574126
What this trial is testing

Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma

Who this might be right for
High Risk Smoldering Multiple Myeloma
PETHEMA Foundation 20
Testing effectiveness (Phase 2)Ended earlyNCT01532635
What this trial is testing

A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives

Who this might be right for
Hematologic MalignancyLeukemiaAcute Lymphoblastic Leukemia+9 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT06550895
What this trial is testing

Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 11
Large-scale testing (Phase 3)Looking for participantsNCT03937635
What this trial is testing

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
ECOG-ACRIN Cancer Research Group 288
Testing effectiveness (Phase 2)Study completedNCT00003401
What this trial is testing

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Maryland, Baltimore
Testing effectiveness (Phase 2)Active Not RecruitingNCT03606577
What this trial is testing

An Intensive Program With Quadruplet Induction and Consolidation Plus Tandem Autologous Stem Cell Transplantation in Newly Diagnosed High Risk Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Nantes University Hospital 50
Early research (Phase 1)Looking for participantsNCT05544019
What this trial is testing

Study of SGR-1505 in Mature B-Cell Neoplasms

Who this might be right for
Mature B-Cell NeoplasmNon Hodgkin LymphomaDLBCL+23 more
Schrödinger, Inc. 98
Not applicableStudy completedNCT00060021
What this trial is testing

Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation

Who this might be right for
Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)WithdrawnNCT03952832
What this trial is testing

Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
City of Hope Medical Center
Early research (Phase 1)Study completedNCT01163357
What this trial is testing

Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant RecipientLoss of Chromosome 17pPlasma Cell Leukemia+2 more
City of Hope Medical Center 18
Testing effectiveness (Phase 2)Ended earlyNCT02128230
What this trial is testing

UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

Who this might be right for
Multiple Myeloma
University of Arkansas 20
Large-scale testing (Phase 3)Looking for participantsNCT07413809
What this trial is testing

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

Who this might be right for
Multiple Myeloma
The Affiliated People's Hospital of Ningbo University 92
Early research (Phase 1)Study completedNCT01330173
What this trial is testing

Vismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma

Who this might be right for
DS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell MyelomaDS Stage III Plasma Cell Myeloma+1 more
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT00278161
What this trial is testing

Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 94
Early research (Phase 1)Looking for participantsNCT05836896
What this trial is testing

A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell Malignancies

Who this might be right for
NeoplasmsRelapsed Diffuse Large B-cell Lymphoma (DLBCL)Refractory Diffuse Large B-cell Lymphoma (DLBCL)+2 more
Technische Universität Dresden 16
Testing effectiveness (Phase 2)WithdrawnNCT01125449
What this trial is testing

Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease

Who this might be right for
SarcomaAdenocarcinomaCarcinoma+2 more
Situs Cancer Research Center
Next Page